透過您的圖書館登入
IP:18.226.96.61
  • 期刊
  • OpenAccess

眼前段視網膜冷凍法對糖尿病性玻璃體出血的治療

Anterior Retinal Cryopexy in Diabetic Vitreous Hemorrhage

摘要


本篇收集增殖性糖尿病視網膜病變併發中度至重度玻璃體出血達三個月以上仍無法吸收,無法再使用雷射治療的病人共61位71例,將其分為二組,冷凍組37人,40例;對照組24人,31例;觀察其出血吸收情形、視力的變化,併發症及二組的比較。結果在冷凍組40例中,完全吸收17例(42.5%),部分吸收18例(45%);對照組31例中,完全吸收僅1例(3.2%),部分吸收8例(26%),具明顯統計意義;視力方面:冷凍組中變好23例(58%),變差13例(32%);而對照組中變好14例(46%),變差13例(42%),二組無統計上差異;在併發症方面,冷凍組主要是牽引性視網膜剝離9例(22.5%),復發性玻璃體出血7例(18.5%);對照組中無牽引性視網膜剝離,復發性玻璃體出血8例(25.8%)。

關鍵字

無資料

並列摘要


We performed anterior retinal cryopexy (ARC) in 50 eyes of 37 consecutive diabetic patients with vitreous hemorrhage retained for at least 3 months. Another 31 eyes of 24 diabetic patients with similar condition was followed without cryopexy as control group. The mean followed period was 17.4 months in cryopexy patients and 24 months in control group. During the last visit, vitreous hemorrhage was completely absorpted in 42.5% (17/40) of cryopexy group which was significantly higher than control group 3.2% (1/31). Partial absorption of vitreous hemorrhage happened in 45% (18/40) versus 26% (8/31) in control group. The vision improved in 58% (23/40) of cases versus 45% (14/31) in control group although the effect was non-significant statistically. The main complications after cryopexy were tractional retinal detachment 22.5% (9/40) and recurrent vitreous hemorrhage 17.5% (7/40). No tractional retinal detachment happened in control group but recurrent vitreous hemorrhage was 25.8% (8/31).

延伸閱讀